Literature DB >> 2691332

A reliable method for random mutagenesis: the generation of mutant libraries using spiked oligodeoxyribonucleotide primers.

J D Hermes1, S M Parekh, S C Blacklow, H Köster, J R Knowles.   

Abstract

A new procedure for the production of a defined library of random mutants is described. Long spiked oligodeoxyribonucleotides (oligos), in which a predetermined level of the three 'wrong' phosphoramidites are used at each position, are made as primers for a standard oligo-directed mutagenesis protocol. Spiked oligo synthesis on a DNA synthesizer is achieved using an in-line mixing procedure that only requires five phosphoramidite reservoirs and which avoids contamination of any of the pure phosphoramidite reagents. Immutable positions (i.e., positions in the oligo for which pure reagents are used) can be specified, and a silent 'marker' base can be included that allows an early estimate of the mutagenesis efficiency. The randomness of the library in respect to the number, type, and position of the altered bases, is easily verified by DNA sequencing. This procedure has been used to generate a random mutant library of the gene encoding a sluggish triosephosphate isomerase. Among the transformants from this library, a number of second-site suppressor mutations have been found that increase the specific catalytic activity of the starting isomerase. This approach provides a more complete library than a method using chemical mutagenic reagents.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2691332     DOI: 10.1016/0378-1119(89)90148-0

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  26 in total

1.  Reverse engineering the (beta/alpha )8 barrel fold.

Authors:  J A Silverman; R Balakrishnan; P B Harbury
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

2.  Optimizing doped libraries by using genetic algorithms.

Authors:  D Tomandl; A Schober; A Schwienhorst
Journal:  J Comput Aided Mol Des       Date:  1997-01       Impact factor: 3.686

3.  Role of negative regulation in promoter specificity of the homologous transcriptional activators Ace2p and Swi5p.

Authors:  P R Dohrmann; W P Voth; D J Stillman
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

4.  Hydron transfer catalyzed by triosephosphate isomerase. Products of the direct and phosphite-activated isomerization of [1-(13)C]-glycolaldehyde in D(2)O.

Authors:  Maybelle K Go; Tina L Amyes; John P Richard
Journal:  Biochemistry       Date:  2009-06-23       Impact factor: 3.162

5.  Mutant profiles of selectable genetic elements.

Authors:  H Wurst; F M Pohl
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

6.  Novel Bcl-2 homology-3 domain-like sequences identified from screening randomized peptide libraries for inhibitors of the pro-survival Bcl-2 proteins.

Authors:  Erinna F Lee; Anna Fedorova; Kerry Zobel; Michelle J Boyle; Hong Yang; Matthew A Perugini; Peter M Colman; David C S Huang; Kurt Deshayes; W Douglas Fairlie
Journal:  J Biol Chem       Date:  2009-09-10       Impact factor: 5.157

7.  Mutational analysis of a conserved motif of Agrobacterium tumefaciens VirD2.

Authors:  A M Vogel; J Yoon; A Das
Journal:  Nucleic Acids Res       Date:  1995-10-25       Impact factor: 16.971

8.  An early A-signal-dependent gene in Myxococcus xanthus has a sigma 54-like promoter.

Authors:  I M Keseler; D Kaiser
Journal:  J Bacteriol       Date:  1995-08       Impact factor: 3.490

9.  Novel ceftazidime-resistance beta-lactamases generated by a codon-based mutagenesis method and selection.

Authors:  Paul Gaytán; Joel Osuna; Xavier Soberón
Journal:  Nucleic Acids Res       Date:  2002-08-15       Impact factor: 16.971

10.  Asymmetric cross-regulation between the nitrate-responsive NarX-NarL and NarQ-NarP two-component regulatory systems from Escherichia coli K-12.

Authors:  Chris E Noriega; Hsia-Yin Lin; Li-Ling Chen; Stanly B Williams; Valley Stewart
Journal:  Mol Microbiol       Date:  2009-12-04       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.